A prospective study of multiple donor exposure blood recipients: Surveillance value and limitations for hemovigilance

Transfusion

Volumn 50, Issue 1, 2010, Pages 128-138

  Zou, Shimian ^a,b,c   Wu, Yanyun ^a,b,c   Cable, Ritchard ^a,b,c   Dorsey, Kerri ^a,b,c   Tang, Yanlin ^a,b,c   Hapip, Cheryl Anne ^a,b,c   Melmed, Russell ^a,b,c   Trouern Trend, Jonathan ^a,b,c   Carrano, Donna ^a,b,c   Champion, Melanie ^a,b,c   Fujii, Karen ^a,b,c   Fang, Chyang ^a,b,c   Dodd, Roger ^a,b,c  

^a HOLLAND LABORATORY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NUCLEIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; EXPOSURE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PILOT STUDY; PROSPECTIVE STUDY; RECIPIENT; SEROCONVERSION; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 73649108905     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02386.x     Document Type: Article

References (34)

1. Dodd RY, Notari EP 4th., Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 975 9.
2. Zou S, Notari EP 4th., Stramer SL, Wahab F, Musavi F, Dodd RY ARCNET Research Group. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995-2002: American Red Cross blood donor study. Transfusion 2004 44 : 1640 7.
3. Roth VR, Kuehnert MJ, Haley NR, Gregory KR, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Elder KV, Jarvis WR. Evaluation of a reporting system for bacterial contamination of blood components in the United States. Transfusion 2001 41 : 1486 92.
4. Kleinman SH, Glynn SA, Higgins MJ, Triulzi DJ, Smith JW, Nass CC, Garratty G, Murphy EL, LeParc GF, Schreiber GB, King MR, Chamberland ME, Nemo GJ. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion 2005 45 : 1073 83.
5. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med 1981 304 : 989 94.
6. Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981 246 : 630 4.
7. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989 321 : 1494 500.
8. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991 325 : 1325 9.
9. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, Kim JP. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997 336 : 747 54.
10. Umemura T, Yeo AE, Sottini A, Moratto D, Tanaka Y, Wang RY, Shih JW, Donahue P, Primi D, Alter HJ. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001 33 : 1303 11. (Pubitemid 32378231)
11. Alter HJ, Busch MP, Schechterly CA, Colvin CA, Lee TH, Drew WL, Mbisa G, Conde-Ortiz BA, Whitby D, Luban NL. A prospective study of transfusion- transmitted HIV, HBV, HCV, CMV, HHV-8 (KSHV) and EBV infections [abstract]. Transfusion 2007 47 (3S 16A 17A.
12. Jordan J, Tiangco B, Kiss J, Koch W. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 1998 75 : 97 102.
13. Brown KE, Young NS, Alving BM, Barbosa LH. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 2001 41 : 130 5.
14. Weimer T, Streichert S, Watson C, Gröner A. High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 2001 41 : 1500 4.
15. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002 15 : 485 505.
16. Thomas I, Di Giambattista M, Gérard C, Mathys E, Hougardy V, Latour B, Branckaert T, Laub R. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 2003 84 : 300 7.
17. Boman J, Söderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waldenström A, Wadell G. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998 178 : 274 7.
18. Kaul R, Uphoff J, Wiedeman J, Yadlapalli S, Wenman WM. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation 2000 102 : 2341 6.
19. Maass M, Jahn J, Gieffers J, Dalhoff K, Katus HA, Solbach W. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis 2000 181 Suppl 3 : S449 S451.
20. Haranaga S, Yamaguchi H, Leparc GF, Friedman H, Yamamoto Y. Detection of Chlamydia pneumoniae antigen in PBMNCs of healthy blood donors. Transfusion 2001 41 : 1114 9.
21. Hedin G, Eriksson I, Kumlin U, Boman J. A lack of serologic evidence of transmission of Chlamydia pneumoniae by transfusion of buffy coat-depleted RBCs. Transfusion 2003 43 : 646 50.
22. Leiby DA. Chlamydia pneumonia: another agent added to the growing list of transfusion-transmitted pathogens? Transfusion 2003 43 : 552 5.
23. Hapip CA, Xu D, Fang CT, Melmed RS, Cable RG. Seroprevalence of parvovirus B19, cytomegalovirus and Chlamydia pneumoniae among randomly selected blood donors [abstract]. Transfusion 2005 45 (3S 104A.
24. Tang Y, Liu B, Hapip CA, Fang CT. Development of TaqMan PCR assays for detection and quantification of cytomegalovirus, Chlamydia pneumoniae and parvovirus B19 [abstract]. Transfusion 2005 45 (3S 104A.
25. Spiegelberg HL, Fishkin BG. The catabolism of human G immunoglobulins of different heavy chain subclasses. 3. The catabolism of heavy chain disease proteins and of Fc fragments of myeloma proteins. Clin Exp Immunol 1972 10 : 599 607.
26. Jaggi JS, Carrasquillo JA, Seshan SV, Zanzonico P, Henke E, Nagel A, Schwartz J, Beattie B, Kappel BJ, Chattopadhyay D, Xiao J, Sgouros G, Larson SM, Scheinberg DA. Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. J Clin Invest 2007 117 : 2422 30.
27. Plentz A, Hahn J, Knöll A, Holler E, Jilg W, Modrow S. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 2005 45 : 1811 5.
28. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study (REDS-II). Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007 47 : 1756 64.
29. Schmidt M, Themann A, Drexler C, Bayer M, Lanzer G, Menichetti E, Lechner S, Wessin D, Prokoph B, Allain JP, Seifried E, Hourfar MK. Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 2007 47 : 1775 82.
30. Yu MW, Virata-Theimer ML, Geng Y, Schechterly CA, Colvin CA, Alter HJ, Luban NL. Transmission of parvovirus B19 by blood transfusion confirmed by DNA sequencing [abstract]. Transfusion 2007 47 (3S 16A.
31. Kleinman S, Glynn S, Lee TH, Tobler L, Schlumpf K, Todd D, Busch MP. A linked donor and recipient study of B19 viral transmission by blood component transfusion [abstract]. Transfusion 2008 48 Suppl : 33A.
32. Brown KE, Simmonds P. Parvoviruses and blood transfusion. Transfusion 2007 47 : 1745 50.
33. Parsyan A, Candotti D. Human erythrovirus B19 and blood transfusion - an update. Transfus Med 2007 17 : 263 78.
34. West SK, Kohlhepp SJ, Jin R, Gleaves CA, Stamm W, Gilbert DN. Detection of circulating chlamydophila pneumoniae in patients with coronary artery disease and healthy control subjects. Clin Infect Dis 2009 48 : 560 7.